Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.

Journal of surgical oncology - 1 Dec 2011

Su Chung-Kuang, Yeh Kun-Tu, Yeh Chao-Bin, Wang Po-Hui, Ho Esther Shih-Chu, Chou Ming-Chih, Liu Kai-Cheng, Yang Shun-Fa, Yi Yu-Chiao

Abstract excerpt

BACKGROUND AND OBJECTIVES: To investigate the association of uPA system genes, including uPA, uPA receptor (uPAR), and plasminogen activator inhibitor (PAI)-1 gene polymorphisms, with risk of endometrial cancer. METHODS: In the present case control study, we enrolled a total of 134 patients with endometrial cancer confirmed by histopathology and 302 unrelated healthy individuals. Genetic polymorphisms of uPA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Logistic Models

Share to Plasminogen Activator Inhibitor 1

Share to Receptors, Urokinase Plasminogen Activator

Share to Taiwan

Share to Urokinase-Type Plasminogen Activator

Source

Identifiers

PMID: 21761413
DOI: 10.1002/jso.22035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.PMID 21761413Read ↗

Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.Semantic proximity Read ↗

Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma.Semantic proximity Read ↗

The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.Semantic proximity Read ↗

The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive RoleSemantic proximity Read ↗

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasisSemantic proximity Read ↗

PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.Semantic proximity Read ↗

What is the impact of plasminogen activator inhibitor type 1 (PAI-1) gene polymorphism on gynecological malignancies: a retrospective studySemantic proximity Read ↗

Impact of uPA system gene polymorphisms on the susceptibility of environmental factors to carcinogenesis and the development of clinicopathology of oral cancer.Semantic proximity Read ↗

Polymorphisms in IL-1A are associated with endometrial cancer susceptibility among Chinese Han population: A case-control study.Semantic proximity Read ↗

Diversity and functional evolution of the plasminogen activator system.Semantic proximity Read ↗

Significant association of urokinase plasminogen activator Pro141Leu with serum lipid profiles in a Japanese population.Semantic proximity Read ↗

A C to T polymorphism of urokinase plasminogen activator (P141L) is associated with Helicobacter pylori infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.